These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 24760454)
1. [Use of Bone Morphogenetic Proteins (BMPs) for the Treatment of Pseudarthroses - Efficiency and Therapy Failure]. Hausmann M; Ehnert S; Hofmann V; Döbele S; Freude T; Stöckle U; Nussler A Z Orthop Unfall; 2014 Apr; 152(2):144-51. PubMed ID: 24760454 [TBL] [Abstract][Full Text] [Related]
2. Treatment of congenital pseudarthrosis of the tibia with native bovine BMP: a case report. Kujala S; Vähäsarja V; Serlo W; Jalovaara P Acta Orthop Belg; 2008 Feb; 74(1):132-6. PubMed ID: 18411616 [TBL] [Abstract][Full Text] [Related]
3. Bone morphogenetic proteins in clinical applications. Gautschi OP; Frey SP; Zellweger R ANZ J Surg; 2007 Aug; 77(8):626-31. PubMed ID: 17635273 [TBL] [Abstract][Full Text] [Related]
4. Recombinant human bone morphogenetic proteins in the treatment of fractures. Kain MS; Einhorn TA Foot Ankle Clin; 2005 Dec; 10(4):639-50, viii. PubMed ID: 16297824 [TBL] [Abstract][Full Text] [Related]
5. Is there a role for bone morphogenetic proteins in osteoporotic fractures? Kanakaris NK; Petsatodis G; Tagil M; Giannoudis PV Injury; 2009 Dec; 40 Suppl 3():S21-6. PubMed ID: 20082786 [TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic proteins in open fractures: past, present, and future. Nauth A; Ristiniemi J; McKee MD; Schemitsch EH Injury; 2009 Dec; 40 Suppl 3():S27-31. PubMed ID: 20082787 [TBL] [Abstract][Full Text] [Related]
12. [Fracture repair and bone morphogenetic protein (BMP)]. Nakase T; Yoshikawa H Clin Calcium; 2006 May; 16(5):755-65. PubMed ID: 16679616 [TBL] [Abstract][Full Text] [Related]
13. Clinical applications of BMPs. De Biase P; Capanna R Injury; 2005 Nov; 36 Suppl 3():S43-6. PubMed ID: 16188549 [TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic proteins in musculoskeletal medicine. Giannoudis PV; Einhorn TA Injury; 2009 Dec; 40 Suppl 3():S1-3. PubMed ID: 20082783 [TBL] [Abstract][Full Text] [Related]
15. Use of bone morphogenetic proteins for augmentation of bone regeneration. Kirker-Head CA; Boudrieau RJ; Kraus KH J Am Vet Med Assoc; 2007 Oct; 231(7):1039-55. PubMed ID: 17916029 [TBL] [Abstract][Full Text] [Related]
16. Immunolocalization of BMPs, BMP antagonists, receptors, and effectors during fracture repair. Yu YY; Lieu S; Lu C; Miclau T; Marcucio RS; Colnot C Bone; 2010 Mar; 46(3):841-51. PubMed ID: 19913648 [TBL] [Abstract][Full Text] [Related]
17. Effects of pleiotrophin (PTN) over-expression on mouse long bone development, fracture healing and bone repair. Li G; Bunn JR; Mushipe MT; He Q; Chen X Calcif Tissue Int; 2005 Apr; 76(4):299-306. PubMed ID: 15812580 [TBL] [Abstract][Full Text] [Related]
18. Interplay between bone morphogenetic proteins and cognate binding proteins in bone and cartilage development: noggin, chordin and DAN. Reddi AH Arthritis Res; 2001; 3(1):1-5. PubMed ID: 11178121 [TBL] [Abstract][Full Text] [Related]
19. The role of endogenous bone morphogenetic proteins in normal skeletal repair. Marsell R; Einhorn TA Injury; 2009 Dec; 40 Suppl 3():S4-7. PubMed ID: 20082790 [TBL] [Abstract][Full Text] [Related]
20. Design of second generation therapeutic recombinant bone morphogenetic proteins. Alaoui-Ismaili MH; Falb D Cytokine Growth Factor Rev; 2009; 20(5-6):501-7. PubMed ID: 19910235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]